| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |